This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
概述
趣赢平台 is at the forefront of health research, and our biostatisticians and epidemiologists bring innovative approaches to address a wide range of clinical trial, 观察, 以及监控研究. Our clients rely on us for expert methodology, 创新基础设施, 经验丰富的协调, 以及可操作的结果. Our research pushes the boundaries of public health knowledge, investigating important issues such as the household transmission rates of COVID-19 and the comparative effectiveness of Food and Drug Administration (FDA)-approved influenza vaccines.
我们的专业知识
Biostatistical方法
促进健康, 趣赢平台 biostatisticians expertly apply appropriate methods to address a wide array of scientific questions in both 观察 and clinical science. Our analyses include anywhere from a handful of patients in a clinical setting to millions in an electronic health record (EHR) system, sometimes each with hundreds of data points. When an existing method does not meet the needs of a study or the implications of an analytic choice are unclear, we develop and test new methods in collaboration with our clients.
流行病学研究
趣赢平台’s epidemiologists have supported critical epidemiological research studies, utilizing various study methods and designs to assess data retrospectively and prospectively. 趣赢平台 has developed and utilized innovative tools and methods to provide clients with research services that support epidemiologic studies related to both communicable and non-communicable diseases. 趣赢平台’s epidemiologic studies have supported research that has direct policy implications such as collaborating to produce the White House Reports on Long COVID, information about household transmission of SARS-CoV-2, and COVID-19 vaccine effectiveness estimates.
疾病监测
趣赢平台 is committed to using our expertise in epidemiology, 统计数据, and public health to strengthen disease surveillance. 我们监测趋势的努力, 识别前哨事件, and track key metrics provide decisionmakers with critical situational awareness. Partnering with federal and state agencies in fields ranging from infectious disease to substance abuse, we apply rigorous methodology to both traditional and innovative data collection and analysis, generating timely insights to support public health action.
专家
认识团队
-
莎拉球
副总统 & Lead Scientific/Epidemiology Advisor
-
芭芭拉·奥布莱恩
助理副总裁
-
凯伦·德拉·托雷
助理副总裁
-
迪帕克B. Khatry
副主任
-
珍妮·罗森塔尔
副总统
-
克里·格蕾丝·莫里西
副总统
-
玛莎邓恩
副总统
-
丽贝卡·芬克
首席研究科学家
项目
继续阅读
-
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
How does our support for clinical trials reduce new HIV infections and improve care for young people? -
国家癌症研究所(NCI)
癌症筛查能拯救生命吗? -
Children’s Hospital of Philadelphia
How do you meet data management and biostatistical expertise needs for a hospital?
的见解
与我们的专家深入探讨
-
的角度来看
The 趣赢平台 Team Behind VISION’s Success2024年4月
The VISION Vaccine Effectiveness Network, launched by the Centers for Disease Control and Prevention (CDC) in 2020, spurred a monumental shift in vaccine assessment, 指导……
-
的角度来看
VISION Vaccine Effectiveness Network: Why It Succeeded2023年9月
With the emergency phase of the COVID-19 pandemic behind us, interest has grown in understanding why the VISION Vaccine Effectiveness (VE) Network, 2020年推出…
-
的角度来看
Solving the Challenges to Clinical Trial Research in an Uncertain Economy2023年1月
全球流行病, 在早期阶段, brought a hailstorm of challenges to businesses, including the business of conducting clinical trials. 而我们西方的同事…